Skip to main content
. 2016 Jun 8;12:1319–1331. doi: 10.2147/NDT.S104777

Table 4.

Descriptive statistics

Measures Baseline
Posttreatment
3-Month FU
Mean SD Mean SD Mean SD
Depression
 GRID-HAMD 14.3 4.5 9.7 4.3 8.4 3.7
 BDI-II 15.3 7.9 12.5 4.9 12.8 7.1
 HADS-Depression 7.9 4.5 5.9 4.1 6.0 3.9
Anxiety
 HADS-Anxiety 7.1 4.1 6.1 4.0 6.3 3.7
 STAI 46.4 13.0 43.6 8.0 44.5 9.9
 OASIS 5.8 3.7 4.3 3.2 6.2 4.2
QOL (SF-36)
 Physical function 68.2 16.3 71.6 15.4 71.8 18.6
 Role physical 58.5 27.1 64.5 23.8 68.1 26.4
 Bodily pain 52.5 25.4 57.4 23.5 52.6 23.3
 General health perceptions 36.2 14.5 36.6 14.1 38.7 21.0
 Vitality 41.1 20.6 46.3 14.2 49.0 16.8
 Social functioning 64.5 24.0 65.8 26.0 72.4 23.0
 Role emotional 64.0 23.8 73.2 23.5 70.2 23.1
 Mental health 61.8 17.6 68.9 12.6 66.6 16.9
L-Dopa
 L-Dopa equivalence rate (SD) 447.4 283.0 441.0 265.4 435.2 254.9

Abbreviations: FU, follow-up; SD, standard deviation; GRID-HAMD, GRID-Hamilton Rating Scale for Depression; BDI-II, Beck Depression Inventory-II; HADS, Hospital Anxiety and Depression Scale; STAI, State and Trait Anxiety Inventory; OASIS, Overall Anxiety Severity and Impairment Scale; QOL, quality of life; SF-36, MOS 36-Item Short-Form Health Survey; MOS, Medical Outcomes Study.